5544.5000 49.50 (0.90%)
NSE Sep 23, 2025 15:31 PM
Volume: 240.2K
 

5544.50
0.90%
Reliance Securities
ff US FDA: Alkem is yet to receive The US FDA clearance for St. Louis facility. However, it has already received EIR for Daman unit (inspected in Mar'18), while the US FDA inspected its Baddi plant between 6-10th Aug-18 with zero observations....
ICICI Securities Limited increased Buy price target of Alkem Laboratories Ltd. to 6400.0 on 19 Sep, 2025.
More from Alkem Laboratories Ltd.
Recommended